Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GPCR | AZN | AMGN | GILD | BMY |
| Company | Structure Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 43.93 | 185.45 | 332.52 | 130.00 | 60.02 |
| High | 44.66 | 187.18 | 337.00 | 131.51 | 60.09 |
| Low | 42.02 | 184.01 | 324.63 | 129.01 | 58.03 |
| Latest | 42.22 | 184.91 | 325.84 | 130.66 | 58.63 |
| Change | +0.77 | -2.46 | -20.41 | -0.18 | -1.96 |
| % Change | +1.86% | -1.31% | -5.89% | -0.14% | -3.23% |
| Volume | 734,420 | 875,823 | 1,747,735 | 1,386,860 | 6,711,022 |
| 20-Day Average Volume | 892,103 | 1,990,242 | 2,449,906 | 5,134,007 | 9,255,874 |
| Previous Close | 41.45 | 187.37 | 346.25 | 130.84 | 60.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 49.16 | 196.72 | 345.82 | 135.52 | 58.78 |
| 20-Day Raw Stochastic | 9.79% | 9.66% | 2.79% | 19.90% | 43.96% |
| 20-Day Relative Strength | 34.16 | 39.10 | 36.56 | 39.51 | 49.70 |
| Weighted Alpha | -25.72 | +23.11 | +11.56 | +21.07 | +21.32 |
| Today's Opinion | 40% Sell | 24% Buy | 8% Sell | 8% Sell | 56% Buy |
| Previous Opinion | 40% Sell | 40% Buy | 8% Buy | Hold | 72% Buy |
| Last Month's Opinion | 8% Buy | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.01% since 04/24/26 | -2.92% since 04/24/26 | -5.50% since 04/24/26 | +0.22% since 04/24/26 | +0.13% since 04/24/26 |
| Low | 40.68 on 04/29/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 47.49 on 04/27/26 | 190.59 on 04/27/26 | 349.54 on 04/30/26 | 132.21 on 04/30/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | -15.69% since 04/01/26 | -8.23% since 04/01/26 | -7.84% since 04/01/26 | -6.85% since 04/01/26 | -4.77% since 04/01/26 |
| Low | 40.68 on 04/29/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 57.22 on 04/08/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -52.18% since 01/30/26 | -0.72% since 01/30/26 | -4.76% since 01/30/26 | -7.93% since 01/30/26 | +6.78% since 01/30/26 |
| Low | 40.68 on 04/29/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 92.06 on 02/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +26.95% since 10/31/25 | +11.77% since 10/31/25 | +9.10% since 10/31/25 | +9.10% since 10/31/25 | +27.60% since 10/31/25 |
| Low | 30.94 on 12/04/25 | 160.96 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 94.90 on 12/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,936,401 | 290,593,632 | 186,865,936 | 162,401,488 | 123,708,720 |
| Shares Outstanding, K | 70,842 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -141,200,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 33,000,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -1.17 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 02/26/26 | 2.12 on 02/10/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/14/26 | 08/04/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.00 | 15.47 | 15.81 | 9.36 |